| Literature DB >> 16489003 |
Stephanie Thebault1, Matthieu Flourakis, Karine Vanoverberghe, Franck Vandermoere, Morad Roudbaraki, V'yacheslav Lehen'kyi, Christian Slomianny, Benjamin Beck, Pascal Mariot, Jean-Louis Bonnal, Brigitte Mauroy, Yaroslav Shuba, Thierry Capiod, Roman Skryma, Natalia Prevarskaya.
Abstract
One major clinical problem with prostate cancer is the cells' ability to survive and proliferate upon androgen withdrawal. Because Ca2+ is central to growth control, understanding the mechanisms of Ca2+ homeostasis involved in prostate cancer cell proliferation is imperative for new therapeutic strategies. Here, we show that agonist-mediated stimulation of alpha1-adrenergic receptors (alpha1-AR) promotes proliferation of the primary human prostate cancer epithelial (hPCE) cells by inducing store-independent Ca2+ entry and subsequent activation of nuclear factor of activated T cells (NFAT) transcription factor. Such an agonist-induced Ca2+ entry (ACE) relied mostly on transient receptor potential canonical 6 (TRPC6) channels, whose silencing by antisense hybrid depletion decreased both hPCE cell proliferation and ACE. In contrast, ACE and related growth arrest associated with purinergic receptors (P2Y-R) stimulation involved neither TRPC6 nor NFAT. Our findings show that alpha1-AR signaling requires the coupled activation of TRPC6 channels and NFAT to promote proliferation of hPCE cells and thereby suggest TRPC6 as a novel potential therapeutic target.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16489003 DOI: 10.1158/0008-5472.CAN-05-0376
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701